ArticlePLoS medicine2021

Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: A validation study.

Winnie Chua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.